DRIO logo

DRIO
DarioHealth Corp

3,498
Mkt Cap
$61.32M
Volume
42,137.00
52W High
$17.74
52W Low
$5.94
PE Ratio
-0.55
DRIO Fundamentals
Price
$7.61
Prev Close
$8.40
Open
$8.44
50D MA
$9.92
Beta
0.86
Avg. Volume
12,100.44
EPS (Annual)
-$10.12
P/B
0.85
Rev/Employee
$135,509.09
$50.83
Loading...
Loading...
News
all
press releases
DarioHealth (NASDAQ:DRIO) Shares Cross Below Two Hundred Day Moving Average - Here's Why
DarioHealth (NASDAQ:DRIO) Shares Cross Below 200 Day Moving Average - Here's Why...
MarketBeat·9d ago
News Placeholder
More News
News Placeholder
DarioHealth (NASDAQ:DRIO) Price Target Lowered to $10.00 at Stifel Nicolaus
Stifel Nicolaus decreased their price objective on DarioHealth from $16.00 to $10.00 and set a "buy" rating on the stock in a research report on Friday...
MarketBeat·17d ago
News Placeholder
DarioHealth (DRIO) Q4 2025 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·18d ago
News Placeholder
DarioHealth Q4 Earnings Call Highlights
DarioHealth (NASDAQ:DRIO) executives highlighted record commercial momentum and continued cost reductions on the company's fourth-quarter and year-end 2025 earnings call, while also addressing the revenue impact of a single legacy customer non-renewal and outlining expectations for accelerating grow...
MarketBeat·18d ago
News Placeholder
DarioHealth (NASDAQ:DRIO) Issues Earnings Results
DarioHealth (NASDAQ:DRIO - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $8.36 earnings per share (EPS) for the quarter, topping analysts' consensus estimates...
MarketBeat·18d ago
News Placeholder
DarioHealth Corp. (DRIO) Reports Q4 Loss, Beats Revenue Estimates
DarioHealth (DRIO) delivered earnings and revenue surprises of +48.88% and +2.17%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·18d ago
News Placeholder
DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results PR Newswire NEW YORK, March...
PR Newswire·18d ago
News Placeholder
Short Interest in DarioHealth Corp. (NASDAQ:DRIO) Drops By 24.6%
DarioHealth Corp. (NASDAQ:DRIO - Get Free Report) saw a significant drop in short interest in February. As of February 27th, there was short interest totaling 50,473 shares, a drop of 24.6% from the...
MarketBeat·23d ago
News Placeholder
DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026
DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026 DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026 PR Newswire NEW...
PR Newswire·26d ago
News Placeholder
Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health
Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital...
PR Newswire·27d ago
<
1
2
...
>

Latest DRIO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.